Adenotonsillar Histopathology After Organ Transplantation
Authors:
- 1 September 2001
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 125 (3) , 231-240
Abstract
OBJECTIVES: The increasing number of surviving pediatric organ transplant recipients has resulted in a new clinical controversy surrounding the significance of adenotonsillar hypertrophy. The objective of this study is to evaluate adenotonsillar specimens, understand characteristic histopathology, and to examine the frequency and significance of this finding in this population.METHODS: Twenty‐one cases of pediatric transplant recipients with adenoidal and/or tonsillar hypertrophy were reviewed retrospectively in a tertiary‐care setting. Particular attention was given to the histopathology of their surgical specimens, including any evidence of posttransplantation lymphoproliferative disorders (PTLD).RESULTS: Using morphologic, immunohistochemical, and molecular genetic analyses, 15 (71%) of 21 patients were noted to have Epstein‐Barr virus (EBV)‐related lymphoid hyperplasia, including 1 case (4.7%) of PTLD. Six (29%) of 21 had evidence of reactive follicular hyperplasia not related to EBV. B‐cell and T‐cell markers were nearly uniformly positive when tested for, except in the single patient with PTLD, who exhibited polymorphic, polyclonal B‐cell morphology. Kappa and lambda light‐chain clonality markers were positive in 11 (92%) of 12 patients.CONCLUSIONS: EBV‐related lymphoid hyperplasia is frequently associated with adenotonsillar hypertrophy in pediatric organ transplant patients (71% of our cases); 92% of those cases tested exhibit polyclonal B‐cell populations. PTLD, an important cause of morbidity and mortality in this population, represented approximately 5% of our cases. The remainder of cases represent follicular hyperplasia unrelated to EBV or lymphoproliferative abnormalities. Characteristic histopathologic findings are presented.Keywords
This publication has 13 references indexed in Scilit:
- The Effectiveness of Tonsillectomy in Diagnosing Lymphoproliferative Disease in Pediatric Patients After Liver TransplantationJAMA Otolaryngology–Head & Neck Surgery, 2000
- Adenotonsillar Enlargement in Pediatric Patients Following Solid Organ TransplantationJAMA Otolaryngology–Head & Neck Surgery, 2000
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- MANAGEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPYTransplantation, 1998
- One Hundred Children Treated With Tacrolimus After Primary Orthotopic Liver TransplantationTransplantation Proceedings, 1998
- Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With TacrolimusTransplantation, 1997
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATIONTransplantation, 1996
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERInfectious Disease Clinics of North America, 1995
- Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1994
- CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDRENTransplantation, 1994